生医光电市场规模、份额、按技术、应用、最终用途和地区分類的成长分析 - 2025-2032 年产业预测

预计到 2023 年生医光电市场规模将达到 652 亿美元，从 2024 年的 726.3 亿美元成长到 2032 年的 1,722.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.4%。

由于对非侵入性诊断技术的需求不断增加，全球生医光电市场正经历显着成长。传统方法通常涉及侵入性手术，使患者面临风险和不适。生医光电利用基于光的技术来分析活组织，无需手术干预即可提供准确、即时的影像解决方案。眼科中的光学相干断层扫描 (OCT) 等技术有助于早期发现眼科疾病，而萤光影像则可改善癌症诊断。随着医疗保健系统优先考虑安全性和效率，生医光电的采用将会加速。光电和分子成像技术的进步将进一步提高影像分辨率，从而能够检测到疾病的早期迹象。量子点和等离子体奈米粒子的创新正在彻底改变生物感测并提高疾病生物标记的特异性。这些技术进步正在拓宽生医光电在诊断和个人化医疗的应用范围，推动市场扩张。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

生医光电市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 体外
• 体内

生医光电市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概览
• 透视成像
• 显微镜
• 内部影像
• 光谱分子
• 分析感测
• 光疗法
• 表面成像
• 生物感测器

生医光电市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概览
• 测试和组件
• 医疗
• 医疗诊断
• 非医疗用途

生医光电市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Carl Zeiss AG（Germany）
• Olympus Corporation（Japan）
• Thorlabs, Inc.（USA）
• Hamamatsu Photonics KK（Japan）
• Nikon Corporation（Japan）
• Coherent, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Bruker Corporation（USA）
• ZEISS Group（Germany）
• Horiba, Ltd.（Japan）
• Photonics Industries International, Inc.（USA）
• MKS Instruments, Inc.（USA）
• Edmund Optics, Inc.（USA）
• Jenoptik AG（Germany）

结论和建议

Biophotonics Market size was valued at USD 65.2 billion in 2023 and is poised to grow from USD 72.63 billion in 2024 to USD 172.27 billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The global biophotonics market is experiencing significant growth driven by the increasing demand for non-invasive diagnostic technologies. Traditional methods often involve invasive procedures, posing risks and discomfort for patients. Biophotonics utilizes light-based techniques to analyze biological tissues, offering accurate, real-time imaging solutions without surgical intervention. Technologies like optical coherence tomography (OCT) in ophthalmology facilitate early detection of eye diseases, while fluorescence imaging enhances cancer diagnosis. As healthcare systems prioritize safety and efficiency, biophotonics adoption accelerates. Advancements in nanophotonics and molecular imaging further enhance image resolution and enable detection of early disease signs. Innovations with quantum dots and plasmonic nanoparticles are revolutionizing biosensing, improving the specificity of disease biomarkers. This technological evolution is broadening the applications of biophotonics in diagnostics and personalized medicine, driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biophotonics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biophotonics Market Segments Analysis

Global Biophotonics Market is segmented by Technology, Application, End Use and region. Based on Technology, the market is segmented into In-Vitro and In-Vivo. Based on Application, the market is segmented into See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging and Biosensors. Based on End Use, the market is segmented into Tests and Components, Medical Therapeutics, Medical Diagnostics and Non-medical Application. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biophotonics Market

The global biophotonics market is primarily driven by the rising demand for non-invasive medical techniques. This innovative field facilitates real-time, high-resolution imaging, which is essential for early detection of diseases and the advancement of precision medicine. As instances of cancer, neurological conditions, and cardiovascular diseases continue to rise, healthcare professionals are increasingly turning to biophotonic technologies. These solutions not only ensure safer diagnostic procedures but also enhance the effectiveness of treatment options, making them a preferred choice in modern healthcare. Consequently, the growing inclination towards biophotonics is significantly propelling the market forward.

Restraints in the Biophotonics Market

The Biophotonics market faces significant constraints primarily due to the high costs associated with its devices and infrastructure, which serve as major hindrances to market growth. The advanced nature of optical imaging systems, laser-based diagnostics, and biosensors requires considerable financial investment, making these technologies less accessible, particularly in developing regions. Moreover, the necessity for skilled professionals to effectively operate these sophisticated technologies exacerbates the overall implementation costs. As a result, these factors collectively impede the widespread adoption and expansion of biophotonics solutions, limiting their potential impact in various sectors, particularly in areas that could greatly benefit from such advancements.

Market Trends of the Biophotonics Market

The biophotonics market is witnessing a significant shift towards personalized healthcare solutions, exemplified by innovative startups like Luma Biophotonics. Established in 2021, Luma is at the forefront of this trend, delivering compact, cost-effective home diagnostic devices that empower individuals to monitor their health conveniently. Utilizing advanced Photonic Integrated Circuits (PICs), their flagship analyzer facilitates multianalyte testing, enabling timely health insights while reducing reliance on clinical visits. The development of polymeric PICs, which offer comparable performance to traditional silicon variants at lower costs, exemplifies a crucial advancement. This democratization of advanced diagnostics not only enhances early disease detection but also promotes tailored treatment approaches, driving substantial growth in the biophotonics market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biophotonics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• In-Vitro
• In-Vivo

Global Biophotonics Market Size by Application & CAGR (2025-2032)

• Market Overview
• See-Through imaging
• Microscopy
• Inside Imaging
• Spectro Molecular
• Analytics Sensing
• Light Therapy
• Surface Imaging
• Biosensors

Global Biophotonics Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Tests and Components
• Medical Therapeutics
• Medical Diagnostics
• Non-medical Application

Global Biophotonics Market Size & CAGR (2025-2032)

• North America (Technology, Application, End Use)
  • US
  • Canada
• Europe (Technology, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Carl Zeiss AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorlabs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coherent, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Photonics Industries International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MKS Instruments, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edmund Optics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jenoptik AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations